Paydirt
FH
Insider

Faheem Hasnain

Director

Faheem Hasnain (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Kura Oncology, Inc. (KURA). The largest single filing was $110K of KURA (10,000 sh × $10.98, as filed), executed Dec 9 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$110K
shares × price, as filed
Last traded
Dec 9 2025
Filed Dec 10 2025

Median ADV $20.0M across their filed names

Open performance
Volume by month
$181K$91K$0Oct 2024Apr 2025Oct 2025Apr 2026Mar 2025 · sells $181KDec 2025 · sells $110K
Buys $0 Sells $291K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
KURA Kura Oncology, Inc. KURA · 0 buys · 2 sells 2 filings
Recent filings
KURASALE Kura Oncology, Inc. View filing → $110K
10,000 sh × $10.98
Exec Dec 9 2025
Filed Dec 10 2025 · 5:30 PM ET
KURASALE Kura Oncology, Inc. View filing → $181K
22,682 sh × $8.00
Exec Mar 21 2025
Filed Mar 24 2025 · 5:30 PM ET